1Yeungnam University, College of Medicine, Department of Pathology, School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, ...
1UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland. 2Systems Biology Ireland, UCD School of Medicine, University College Dublin, ...
1Department of Biological Sciences, New York City College of Technology, City University of New York, Brooklyn, New York. 2Biology and Computer PhD Programs, The CUNY Graduate Center, City University ...
Abstract. TNG462 is a clinical-stage, MTA-cooperative PRMT5 inhibitor currently being evaluated in an ongoing phase I/II clinical trial for solid tumors with MTAP loss. Approximately 10-15% of all ...
Synnovation Therapeutics, Inc., Wilmington, DE.
Creighton University School of Medicine, Omaha, NE.
University of Arkansas for Medical Sciences, Little Rock, AR.
Suzhou Genhouse Pharmaceutical Co., Ltd., Suzhou, China.
The University of Hong Kong, Hong Kong, Hong Kong.
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Search for other works by this author on: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback